中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 11
Nov.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(11): 2636-2641

Effectiveness and safety of two-step percutaneous transhepatic choledochoscopic lithotomy in treatment of complex hepatolithiasis

DOI: 10.3969/j.issn.1001-5256.2021.11.029
  • 1.

    Department of Hepatobiliary, Pancreatic and Splenic Surgery, 3201 Hospital of Xi'an Jiaotong University Health Science Center, Hanzhong, Shaanxi 723000, China

  • 2.

    Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China

Research funding:

Natural Science Foundation of Heilongjiang (H2018025)

  • Received Date: 2021-04-04
  • Accepted Date: 2021-05-10
  • Published Date: 2021-11-20
    Abstract
  •   Objective  To investigate the clinical effect of two-step percutaneous transhepatic choledochoscopic lithotomy (PTCSL) in the treatment of complex hepatolithiasis.  Methods  A retrospective analysis was performed for the clinical data of 118 patients with complex hepatolithiasis who were admitted to 3201 Hospital of Xi'an Jiaotong University Health Science Center from January 2018 to June 2020, and according to the surgical procedure, they were divided into PTCSL group with 60 patients and surgery group with 58 patients. All patients were followed up for half a year to 3 years via telephone and outpatient service. The two groups were compared in terms of general information, perioperative indicators (including time of operation, intraoperative blood loss, incision length, time to first flatus and time to first defecation after surgery, time to extraction of abdominal drainage tube, and length of hospital stay), changes in liver function and inflammatory indicators, postoperative complications (bile leakage, acute cholangitis, wound infection, and venous thrombosis of lower extremities), stone clearance rate and recurrence rate, and quality of life. The two-independent-samples t-test was used for comparison of continuous data between two groups; the paired t-test was used for comparison between different periods of time within group; the chi-square test was used for comparison of categorical data between two groups.  Results  Compared with the surgery group, the PTCSL group had significantly shorter time of operation, time to first flatus and time to first defecation after surgery, and time to extraction of abdominal drainage tube, a significantly lower intraoperative blood loss, and a significantly shorter incision length (all P < 0.05). On day 1 after surgery, both groups had significant reductions in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (P < 0.05) and a significant increase in white blood cell count (WBC) (P < 0.05), and the PTCSL group had significantly lower levels of ALT, AST, and WBC than the surgery group (all P < 0.05). Compared with the surgery group, the PTCSL group had significantly lower incidence rates of postoperative bile leakage (5.0% vs 17.2%, P < 0.05), acute cholangitis (3.3% vs 13.8%, P < 0.05), wound infection (1.7% vs 10.3%, P < 0.05), and venous thrombosis of lower extremities (1.7% vs 12.1%, P < 0.05). Compared with the surgery group, the PTCSL group had a significantly higher stone clearance rate (58.3% vs 37.9%, P < 0.05) and a significantly lower long-term stone recurrence rate (10.0% vs 20.7%, P < 0.05). The PTCSL group had significantly higher quality of life scores than the surgery group (all P < 0.05).  Conclusion  For the treatment of complex hepatolithiasis, two-step PTCSL can effectively remove stones, with the advantages of fast postoperative recovery, low recurrence rate and incidence rate of complications, and high quality of life, and therefore, it is an effective alternative surgical procedure.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    DA COSTA AC, SANTA-CRUZ F, SENA BF, et al. Dedifferentiated liposarcoma of the gallbladder: First reported case[J]. World J Surg Oncol, 2018, 16(1): 221. DOI: 10.1186/s12957-018-1520-5.
    [2]
    LIU XW, CHENG Y, GONG JP. Value of percutaneous transhepatic lithotripsy in treatment of hepatolithiasis[J]. J Clin Hepatol, 2019, 35(7): 1640-1643. DOI: 10.3969/j.issn.1001-5256.2019.07.048.

    刘新文, 程瑶, 龚建平. 经皮经肝胆道镜碎石取石术治疗肝胆管结石的价值[J]. 临床肝胆病杂志, 2019, 35(7): 1640-1643. DOI: 10.3969/j.issn.1001-5256.2019.07.048.
    [3]
    LU H, YANG H, WU L, et al. A novel prognostic model for diagnosing atypical bile duct hyperplasia in patients with intrahepatic lithiasis[J]. Medicine (Baltimore), 2019, 98(17): e15364. DOI: 10.1097/MD.0000000000015364.
    [4]
    LI H, ZHENG J, CAI JY, et al. Laparoscopic VS open hepatectomy for hepatolithiasis: An updated systematic review and meta-analysis[J]. World J Gastroenterol, 2017, 23(43): 7791-7806. DOI: 10.3748/wjg.v23.i43.7791.
    [5]
    CHEN CH, LIN CL, KAO CH. Association between inflammatory bowel disease and cholelithiasis: A nationwide population-based cohort study[J]. Int J Environ Res Public Health, 2018, 15(3): 513. DOI: 10.3390/ijerph15030513.
    [6]
    Biliary Tract Group, Chinese Society of Surgery, Chinese Medical Association. The 2011 Chinese guidelines for the diagnosis and treatment of hepatolithiasis[M]. Beijing: People's Medical Publishing House(PMPH), 2011.

    中华医学会外科学分会胆道外科学组. 2011中国肝胆管结石病诊断治疗指南[M]. 北京: 人民卫生出版社, 2011.
    [7]
    XIA L, XIA YJ, ZHANG L, et al. Diagnosis and treatment of intrahepatic cholangiocarcinoma: Current status and thoughts[J]. J Clin Hepatol, 2020, 36(10): 2380-2385. DOI: 10.3969/j.issn.1001-5256.2020.10.048.

    夏龙, 夏医君, 张磊, 等. 肝内胆管细胞癌的诊疗现状与思考[J]. 临床肝胆病杂志, 2020, 36(10): 2380-2385. DOI: 10.3969/j.issn.1001-5256.2020.10.048.
    [8]
    CHEN ZS, TANG CW, TANG CH, et al. Research advances in the clinical diagnosis of intrahepatic cholangiocarcinoma[J]. J Clin Hepatol, 2019, 35(12): 2638-2643. DOI: 10.3969/j.issn.1001-5256.2019.12.005.

    陈志升, 唐陈伟, 汤朝晖, 等. 肝内胆管癌的临床诊断策略[J]. 临床肝胆病杂志, 2019, 35(12): 2638-2643. DOI: 10.3969/j.issn.1001-5256.2019.12.005.
    [9]
    WANG ZC. Curative effect of ERCP on senile patients with choledocholithiasis and its effect on serum inflammatory factors[J]. Traum Crit Med, 2019, 7(4): 233-235. DOI: 10.16048/j.issn.2095-5561.2019.04.12.

    王超智. 内镜下逆行胆胰管造影术对老年胆总管结石患者疗效研究[J]. 创伤与急危重病医学, 2019, 7(4): 233-235. DOI: 10.16048/j.issn.2095-5561.2019.04.12.
    [10]
    TIAN J, LI JW, CHEN J, et al. Laparoscopic hepatectomy with bile duct exploration for the treatment of hepatolithiasis: An experience of 116 cases[J]. Dig Liver Dis, 2013, 45(6): 493-498. DOI: 10.1016/j.dld.2013.01.003.
    [11]
    WANG P, SUN B, HUANG B, et al. Comparison between percutaneous transhepatic rigid cholangioscopic lithotripsy and conventional percutaneous transhepatic cholangioscopic surgery for hepatolithiasis treatment[J]. Surg Laparosc Endosc Percutan Tech, 2016, 26(1): 54-59. DOI: 10.1097/SLE.0000000000000222.
    [12]
    LU GS, WEN HQ, LIU YM. A experimental study on formation of fistula after percutaneous transhepatic cholangiodrainage (PTCD)[J]. China J Endosc, 2004, 10(11): 44-46, 50. DOI: 10.3969/j.issn.1007-1989.2004.11.016.

    陆光生, 文辉清, 刘衍民. 经皮肝穿刺胆道引流管周瘘道形成的实验研究[J]. 中国内镜杂志, 2004, 10(11): 44-46, 50. DOI: 10.3969/j.issn.1007-1989.2004.11.016.
    [13]
    HAN ZM, SHENG YH, ZHANG FK. Comparison of clinical effects between two different paths of percutaneous transhepatic cholangioscopy in treating complicated intrahepatic and extrahepatic bile duct stones[J]. J Hepatobiliary Surg, 2016, 24(6): 422-425. DOI: 10.3969/j.issn.1006-4761.2016.06.007.

    韩志敏, 盛银行, 张风奎. 经皮肝胆道镜术两种不同路径治疗复杂肝内外胆管结石的临床疗效比较[J]. 肝胆外科杂志, 2016, 24(6): 422-425. DOI: 10.3969/j.issn.1006-4761.2016.06.007.
    [14]
    JIANG XF, ZHANG DW, LU HW, et al. Clinical effective analysis of percutaneous transhepatic cholangioscopic lithotrip by rigid choledochoscopy for 194 patients with intrahepatic stones[J]. Chin J Pract Surg, 2017, 37(8): 896-899. DOI: 10.19538/j.cjps.issn1005-2208.2017.08.16.

    蒋小峰, 张大伟, 卢海武, 等. 经皮经肝胆道镜硬镜碎石术治疗肝内胆管结石194例临床疗效分析[J]. 中国实用外科杂志, 2017, 37(8): 896-899. DOI: 10.19538/j.cjps.issn1005-2208.2017.08.16.
    [15]
    LIU XY, LIU XM, ZHI XT. Comparative effect analysis on hepatolith patients by two different path percutaneous transhepatic cholangioscopic lithotripsy[J]. Chin J Curr Adv Gen Surg, 2015, 18(7): 530-532. DOI: 10.3969/j.issn.1009-9905.2015.07.009.

    刘晓洋, 刘晓明, 智绪亭. 两种不同PTCSL路径治疗肝胆管结石的临床效果比较[J]. 中国现代普通外科进展, 2015, 18(7): 530-532. DOI: 10.3969/j.issn.1009-9905.2015.07.009.
    [16]
    TAO HS, WANG P, SUN BW, et al. One-Step multichannel percutaneous transhepatic cholangioscopic lithotripsy applied in bilateral hepatolithiasis[J]. World J Surg, 2020, 44(5): 1586-1594. DOI: 10.1007/s00268-020-05368-7.
    [17]
    WU C, YOU W, ZHANG L, et al. Clinical efficacy of percutaneous transhepatic lithotripsy with one-step biliary fistulation for the treatment of hepatolithiasis[J]. Clin J Dig Surg, 2020, 19(8): 843-848. DOI: 10.3760/cma.j.cn115610-20200603-00416.

    吴琛, 游伟, 张龙, 等. Ⅰ期经皮经肝胆道造瘘胆道镜取石术治疗肝胆管结石病的临床疗效[J]. 中华消化外科杂志, 2020, 19(8): 843-848. DOI: 10.3760/cma.j.cn115610-20200603-00416.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(6)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (398) PDF downloads(45) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return